kidney disease

News

UK's Mission divests kidney drug to Dimerix for $292m

Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.

News

AZ forges ever-closer ties with China's CSPC Pharma

AstraZeneca has returned to China's CSPC Pharma to fill its R&D pipeline, reaching a new $1.77bn agreement to develop drugs for kidney diseases.

Patients

Hands holding graphic representation of a kidney on a blue background

The forgotten few: Why the kidney transplant system is faili...

While innovation has reshaped therapeutic areas like oncology, transplant medicine has, by comparison, stood still.

News

GSK grows pipeline with 35Pharma takeover, Frontier deal

GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

News

Roche trial offers hope to patients with rare kidney disease

A study of Roche's Gazyva has raised the prospect of a first approved therapy for the rare kidney disorder primary membranous nephropathy.

R&D

Xenotransplantation at the brink of breakthrough: A new era ...

In a landmark procedure performed at Massachusetts General Hospital (MGH) on 25th January 2025, a 66-year-old man with end-stage renal disease (ESRD) received a genetically modif

UK's Mission divests kidney drug to Dimerix for $292m

AZ forges ever-closer ties with China's CSPC Pharma

The forgotten few: Why the kidney transplant system is faili...

GSK grows pipeline with 35Pharma takeover, Frontier deal

Roche trial offers hope to patients with rare kidney disease

Xenotransplantation at the brink of breakthrough: A new era ...

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

kidney disease

Editor's Picks